June 04, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the rAAVrh74 viral vector used in the ...

As developers look to harness the power of AI in their applications, one of the most exciting advancements is the ability to enrich existing databases with semantic understanding through vector search ...